vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and EPLUS INC (PLUS). Click either name above to swap in a different company.

EPLUS INC is the larger business by last-quarter revenue ($614.8M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). EPLUS INC runs the higher net margin — 5.7% vs -10.1%, a 15.8% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 20.3%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 2.3%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

ePlus Inc.(Nasdaq: PLUS) is an American consultative technology solutions provider that provides solutions and advisory and managed services across the technology spectrum, including security, cloud, networking, collaboration, artificial intelligence, and emerging solutions to more than 5,000 customers.

CLOV vs PLUS — Head-to-Head

Bigger by revenue
PLUS
PLUS
1.3× larger
PLUS
$614.8M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+24.4% gap
CLOV
44.7%
20.3%
PLUS
Higher net margin
PLUS
PLUS
15.8% more per $
PLUS
5.7%
-10.1%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
2.3%
PLUS

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
CLOV
CLOV
PLUS
PLUS
Revenue
$487.7M
$614.8M
Net Profit
$-49.3M
$35.1M
Gross Margin
25.8%
Operating Margin
-10.1%
7.1%
Net Margin
-10.1%
5.7%
Revenue YoY
44.7%
20.3%
Net Profit YoY
-123.2%
45.2%
EPS (diluted)
$1.33

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
PLUS
PLUS
Q4 25
$487.7M
$614.8M
Q3 25
$496.6M
$608.8M
Q2 25
$477.6M
$637.3M
Q1 25
$462.3M
Q4 24
$337.0M
$493.2M
Q3 24
$331.0M
$493.4M
Q2 24
$356.3M
$535.7M
Q1 24
$346.9M
Net Profit
CLOV
CLOV
PLUS
PLUS
Q4 25
$-49.3M
$35.1M
Q3 25
$-24.4M
$34.9M
Q2 25
$-10.6M
$37.7M
Q1 25
$-1.3M
Q4 24
$-22.1M
$24.1M
Q3 24
$-9.2M
$31.3M
Q2 24
$7.4M
$27.3M
Q1 24
$-19.2M
Gross Margin
CLOV
CLOV
PLUS
PLUS
Q4 25
25.8%
Q3 25
26.6%
Q2 25
23.3%
Q1 25
Q4 24
25.4%
Q3 24
24.5%
25.8%
Q2 24
30.3%
23.7%
Q1 24
23.6%
Operating Margin
CLOV
CLOV
PLUS
PLUS
Q4 25
-10.1%
7.1%
Q3 25
-4.9%
8.0%
Q2 25
-2.2%
5.7%
Q1 25
-0.3%
Q4 24
-6.4%
3.3%
Q3 24
-2.7%
5.5%
Q2 24
2.0%
5.9%
Q1 24
-6.5%
Net Margin
CLOV
CLOV
PLUS
PLUS
Q4 25
-10.1%
5.7%
Q3 25
-4.9%
5.7%
Q2 25
-2.2%
5.9%
Q1 25
-0.3%
Q4 24
-6.6%
4.9%
Q3 24
-2.8%
6.3%
Q2 24
2.1%
5.1%
Q1 24
-5.5%
EPS (diluted)
CLOV
CLOV
PLUS
PLUS
Q4 25
$1.33
Q3 25
$1.32
Q2 25
$1.43
Q1 25
Q4 24
$0.91
Q3 24
$1.17
Q2 24
$1.02
Q1 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
PLUS
PLUS
Cash + ST InvestmentsLiquidity on hand
$78.3M
$326.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$1.1B
Total Assets
$541.0M
$1.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
PLUS
PLUS
Q4 25
$78.3M
$326.3M
Q3 25
$402.2M
Q2 25
$480.2M
Q1 25
Q4 24
$194.5M
$253.1M
Q3 24
$288.0M
$187.5M
Q2 24
$254.8M
$349.9M
Q1 24
$208.3M
Stockholders' Equity
CLOV
CLOV
PLUS
PLUS
Q4 25
$308.7M
$1.1B
Q3 25
$340.9M
$1.0B
Q2 25
$344.2M
$1.0B
Q1 25
$336.1M
Q4 24
$341.1M
$962.3M
Q3 24
$342.2M
$947.0M
Q2 24
$324.9M
$921.9M
Q1 24
$292.5M
Total Assets
CLOV
CLOV
PLUS
PLUS
Q4 25
$541.0M
$1.8B
Q3 25
$559.7M
$1.8B
Q2 25
$575.0M
$1.8B
Q1 25
$583.7M
Q4 24
$580.7M
$1.8B
Q3 24
$653.0M
$1.7B
Q2 24
$674.2M
$1.7B
Q1 24
$671.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
PLUS
PLUS
Operating Cash FlowLast quarter
$-66.9M
$-87.4M
Free Cash FlowOCF − Capex
$-69.0M
FCF MarginFCF / Revenue
-14.1%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
-2.49×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
PLUS
PLUS
Q4 25
$-66.9M
$-87.4M
Q3 25
$12.1M
$-34.8M
Q2 25
$5.4M
$-99.0M
Q1 25
$-16.3M
Q4 24
$34.8M
$65.7M
Q3 24
$50.0M
$-21.6M
Q2 24
$44.8M
$97.1M
Q1 24
$25.9M
Free Cash Flow
CLOV
CLOV
PLUS
PLUS
Q4 25
$-69.0M
Q3 25
$11.4M
Q2 25
$4.8M
Q1 25
$-16.5M
Q4 24
$33.3M
Q3 24
$49.6M
Q2 24
$44.4M
Q1 24
$25.5M
FCF Margin
CLOV
CLOV
PLUS
PLUS
Q4 25
-14.1%
Q3 25
2.3%
Q2 25
1.0%
Q1 25
-3.6%
Q4 24
9.9%
Q3 24
15.0%
Q2 24
12.5%
Q1 24
7.3%
Capex Intensity
CLOV
CLOV
PLUS
PLUS
Q4 25
0.4%
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.0%
Q4 24
0.5%
Q3 24
0.1%
Q2 24
0.1%
Q1 24
0.1%
Cash Conversion
CLOV
CLOV
PLUS
PLUS
Q4 25
-2.49×
Q3 25
-1.00×
Q2 25
-2.63×
Q1 25
Q4 24
2.72×
Q3 24
-0.69×
Q2 24
6.04×
3.55×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

PLUS
PLUS

All Others Customer End Market$107.0M17%
Technology Customer End Market$89.4M15%
Health Care Customer End Market$81.5M13%
Financial Services Customer End Market$66.1M11%
Professional Services Reporting Unit$64.1M10%
Security$61.1M10%
State And Local Government And Educational Institutions$59.9M10%
Managed Services Reporting Unit$48.8M8%
Other Product$21.1M3%
Collaboration$13.4M2%

Related Comparisons